Investigational Site Number 840002

Salt Lake City, Utah 84112-5550

0 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma, Relapsing-remitting Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma — Completed
• Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple Sclerosis — Stopped early